ClearPoint Neuro (CLPT) Share-based Compensation (2011 - 2026)
ClearPoint Neuro (CLPT) reported Share-based Compensation of $2.0 million for Q1 2026, up 4.45% on a YoY basis from $1.9 million in Q1 2025, and up 0.61% sequentially from $2.0 million in Q4 2025.
ClearPoint Neuro (CLPT) Share-based Compensation (2011 - 2026) Analysis & Trends
ClearPoint Neuro (CLPT) has 15 years of Share-based Compensation data on file, last reported at $2.0 million in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation rose 4.45% year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2026 stood at $9.2 million (up 1008.94% YoY), and the FY2025 full-year result was $8.5 million, up 1899.76% from the prior year.
- Share-based Compensation grew to $2.0 million in Q1 2026, from $2.0 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $10.3 million in Q3 2025 to a low of -$4.8 million in Q4 2024.
- A 5-year average of $2.0 million and a median of $1.8 million in 2024 frame the typical range for Share-based Compensation.
- Peak annual rise in Share-based Compensation reached 29980.0% in 2024, while the deepest fall reached 409.79% in 2024.
- Tracing CLPT's Share-based Compensation over 5 years: stood at $3.8 million in 2022, then tumbled by 59.29% to $1.5 million in 2023, then slumped by 409.79% to -$4.8 million in 2024, then soared by 141.44% to $2.0 million in 2025, then grew by 0.61% to $2.0 million in 2026.
- Business Quant data shows CLPT's Share-based Compensation at $2.0 million in Q1 2026, $2.0 million in Q4 2025, and $10.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | ClearPoint Neuro | 434.51 Mn | 398.91 Mn | 7.76 Mn | 1.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.99 Mn |
| Mar 31, 2026 | 1.99 Mn |
| Dec 31, 2025 | 1.98 Mn |
| Dec 31, 2025 | 1.98 Mn |
| Sep 30, 2025 | 10.34 Mn |
| Sep 30, 2025 | 10.34 Mn |
| Jun 30, 2025 | 3.30 Mn |
| Jun 30, 2025 | 3.30 Mn |
| Mar 31, 2025 | 1.91 Mn |
| Mar 31, 2025 | 1.91 Mn |
| Dec 31, 2024 | -4.78 Mn |
| Dec 31, 2024 | -4.78 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Mar 31, 2024 | 1.50 Mn |
| Mar 31, 2024 | 1.50 Mn |
| Dec 31, 2023 | 1.54 Mn |
| Dec 31, 2023 | 1.54 Mn |